DMG MORI CO., LTD. <6141> - Surged sharply, extending gains for the sixth consecutive session. The stock reached a new year-to-date high in one fell swoop. After the close of trading on the 1st, the previous trading day, the company announced its consolidated earnings results for the first quarter (January-March) of the fiscal year ending December 2026 and revised its full-year earnings forecast. The company raised its full-year sales forecast by 30 billion yen from the previous outlook to 565 billion yen (up 9.7% year-on-year), and increased its net profit forecast by 4.5 billion yen to 15 billion yen (down 37.6% year-on-year). Buying in response to the positive business performance has been dominant. The revision also incorporated the impact of reviewing the assumed exchange rate following the expansion of orders globally and the continuation of the yen's weakness against the euro. For the January-March quarter, sales rose 18.9% year-on-year to 135.531 billion yen, and net profit increased 8.9-fold to 1.488 billion yen.

Plus Alpha Consulting Co.,LTD. <4071> - Soared. The company specializes in text mining that uses natural language processing to extract information from text data, with big data analysis as its strength, and provides cloud services for human resources and marketing support. Its business performance has been tracking extremely well, capturing corporate digital transformation (DX) demand. Under these circumstances, it was revealed that Hong Kong-based investment fund Oasis Management, known as an activist, exceeded the 5% threshold with a shareholding ratio of 8.02% as of the 1st of this month, according to a large shareholding report filed on that date. While the purpose of holding is stated as portfolio investment and material proposal actions, the fund notes that "material proposal actions may be taken to protect shareholder value," which has strongly stimulated Plus Alpha Consulting's stock price.

Nxera Pharma Co., Ltd. <4565> - Surged to the daily limit, hitting a new high. After the close of trading on the 1st, the company announced its consolidated earnings results for the first quarter (January-March) of the fiscal year ending December 2026. The swing to an operating profit of 32.44 billion yen (compared to an operating loss of 21.93 billion yen in the same period of the previous year) appears to have been well received. Sales revenue came in at 112.56 billion yen, up 69.4% year-on-year. The main factor was the achievement of seven milestones (compared to one in the same period of the previous year). In addition, focused narrowing of research and development areas and cost reduction efforts led to decreases in R&D expenses and selling, general and administrative expenses, which contributed to the profit side. The company maintained its full-year earnings forecast at the previous outlook.

*This information may include unconfirmed details. Please make your own investment decisions regarding stock trading at your own risk.

Source: MINKABU PRESS

*Translated by generative AI. Click here for the original article.